News China Shandong: Shandong Xinhua’s Mixed Financial Performance in 2024
Shandong Xinhua Pharmaceutical Company Limited Class H (HK:0719) has released an update.Shandong Xinhua Pharmaceutical Company Limited reported a slight increase in operating income for the first nine months of 2024, reaching approximately RMB 6.73 billion, a 3.64% rise from the same period last year. However, the net profit attributable to shareholders saw a downturn, dropping by 12.22% to around RMB 344 million. Despite the decline in net profit, the company achieved a significant boost in net cash flow from operating activities, which surged by 233.45%.For further insights into HK:0719 stock, check out TipRanks’ Stock Analysis page.
News China Shandong: After May diplomatic blitz, China pivots June toward global business, trade, investment
After a bustling May dominated by high-level diplomacy, China is pivoting its June agenda toward global business, trade, and investment. As a series of major economic platforms kicks off this summer, ...
News China Shandong: China Court Rules Crypto Investment Losses Must Be Self-Borne
A China court dismissed a case tied to losses from a crypto investment, ruling that the investor must face the financial loss caused in crypto activity.
News China Shandong: Boeing, China Will Help You Regain Market Confidence
This may be the case in particular for higher risk stocks such as speculative investments and cryptocurrencies that have helped the market achieve impressive returns in the recent past. Thus, I am ...
News China Shandong: China releases measures to keep foreign trade stable
BEIJING - China on Tuesday unveiled new guidelines to ease pressures on foreign trade companies and keep the country's exports and imports stable. The country will further open up the economy and ...
